Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma

Table 1 Clinical and demographic data of patients with HCC at the time of the diagnosis

Clinical features	mean ± SD or percentage (%)
Age (yr)	55.0 ± 13.6 (range, 26-89)
Sex (male:female)	60:10
Etiology
Alcohol dependence	9/70 (12.8)
HBsAg-positive	39/70 (55.7)
Anti-HCV-positive	7/70 (10)
HBsAg- and anti-HCV-positive	2/70 (2.9)
Unknown	13/70 (18.6)
Liver function test
Total bilirubin (mg%)	2.3 ± 3.5
Albumin (g/dL)	3.5 ± 0.7
AST (IU/L)	150.9 ± 130.4
ALT (IU/L)	82.9 ± 84.1
Alkaline phosphatase (IU/L)	512.0 ± 317.9
Prothrombin time (s)	14.4 ± 4.2
Child-Pugh classification
A	43/70 (61.4)
B	23/70 (32.9)
C	4/70 (5.7)
Okuda staging system
1	19/70 (27.2)
2	46/70 (65.7)
3	5/70 (7.1)
Venous invasion	17/70 (24.3)
Extrahepatic metastasis	12/70 (17.1)
AFP (≥ 400 ng/mL)	27/70 (38.6)